Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07248176 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Universal CAR-T Cell Therapy for MM

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Re-verified, no change to tracked fieldsv2
  2. Minor Study First Submitted
This trial aims to evaluate the safety and efficacy of BCMA-UCART in treating patients with r/r multiple myeloma.
Trial Details
NCT Number NCT07248176
Lead Sponsor Bioray Laboratories
Collaborators: Shanghai Tongji Hospital, Tongji University School of Medicine
Conditions
(from sponsor)
Multiple Myeloma, Multiple Myeloma in Relapse, Multiple Myeloma, Refractory
Related terms Multiple Myeloma
Enrollment 6 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov